These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 33109574)
21. The relationship between the tertiary lymphoid structure and immune-infiltrating cells in gastrointestinal cancers: A systematic review and meta-analysis. Yu A; Fan Z; Ma L; Tang J; Liu W; Han Z; Wang H Immun Inflamm Dis; 2024 Sep; 12(9):e70003. PubMed ID: 39259184 [TBL] [Abstract][Full Text] [Related]
22. Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes. Nohira S; Kuramitsu S; Ohno M; Fujita M; Yamashita K; Nagasaka T; Haimoto S; Sakakura N; Matsushita H; Saito R Anticancer Res; 2024 Aug; 44(8):3615-3621. PubMed ID: 39060050 [TBL] [Abstract][Full Text] [Related]
24. Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer. Barmpoutis P; Di Capite M; Kayhanian H; Waddingham W; Alexander DC; Jansen M; Kwong FNK PLoS One; 2021; 16(9):e0256907. PubMed ID: 34555057 [TBL] [Abstract][Full Text] [Related]
25. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer. Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485 [TBL] [Abstract][Full Text] [Related]
26. High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer. Zhan Z; Shi-Jin L; Yi-Ran Z; Zhi-Long L; Xiao-Xu Z; Hui D; Pan YL; Pan JH Ann Med; 2023 Dec; 55(1):114-126. PubMed ID: 36503344 [TBL] [Abstract][Full Text] [Related]
27. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer. Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J Front Immunol; 2022; 13():962056. PubMed ID: 36189233 [TBL] [Abstract][Full Text] [Related]
28. Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer. Song IH; Heo SH; Bang WS; Park HS; Park IA; Kim YA; Park SY; Roh J; Gong G; Lee HJ Cancer Res Treat; 2017 Apr; 49(2):399-407. PubMed ID: 27488875 [TBL] [Abstract][Full Text] [Related]
29. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. Groeneveld CS; Fontugne J; Cabel L; Bernard-Pierrot I; Radvanyi F; Allory Y; de Reyniès A Eur J Cancer; 2021 May; 148():181-189. PubMed ID: 33743486 [TBL] [Abstract][Full Text] [Related]
30. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure. Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035 [TBL] [Abstract][Full Text] [Related]
32. Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis. Lee M; Heo SH; Song IH; Rajayi H; Park HS; Park IA; Kim YA; Lee H; Gong G; Lee HJ Mod Pathol; 2019 Jan; 32(1):70-80. PubMed ID: 30154578 [TBL] [Abstract][Full Text] [Related]
33. An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes. Kim A; Heo SH; Kim YA; Gong G; Jin Lee H Am J Clin Pathol; 2016 Jul; 146(1):137-44. PubMed ID: 27402610 [TBL] [Abstract][Full Text] [Related]
34. Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors. Zhao Z; Ding H; Lin ZB; Qiu SH; Zhang YR; Guo YG; Chu XD; Sam LI; Pan JH; Pan YL Int J Med Sci; 2021; 18(11):2327-2338. PubMed ID: 33967609 [No Abstract] [Full Text] [Related]
35. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival. Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789 [TBL] [Abstract][Full Text] [Related]
36. Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer. Gu J; Wang J; Sun Y; Mao X; Qian C; Tang X; Wang J; Xie H; Ling L; Zhao Y; Liu X; Zhang K; Pan H; Wang S; Wang C; Zhou W Cancer Med; 2024 Jan; 13(1):e6864. PubMed ID: 38133211 [TBL] [Abstract][Full Text] [Related]
37. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus. Saito A; Kitayama J; Horie H; Koinuma K; Ohzawa H; Yamaguchi H; Kawahira H; Mimura T; Lefor AK; Sata N Cancer Sci; 2020 Nov; 111(11):4012-4020. PubMed ID: 32794612 [TBL] [Abstract][Full Text] [Related]
38. Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study. Lei JX; Wang R; Hu C; Lou X; Lv MY; Li C; Gai B; Wu XJ; Dou R; Cai D; Gao F Int J Surg; 2024 Sep; 110(9):5627-5640. PubMed ID: 38833363 [TBL] [Abstract][Full Text] [Related]
39. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer. Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665 [TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. Kießler M; Plesca I; Sommer U; Wehner R; Wilczkowski F; Müller L; Tunger A; Lai X; Rentsch A; Peuker K; Zeissig S; Seifert AM; Seifert L; Weitz J; Bachmann M; Bornhäuser M; Aust D; Baretton G; Schmitz M J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]